Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART study.
Saved in:
| Title: | Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART study. |
|---|---|
| Authors: | Luong Nguyen LB; INSERM, F-CRIN, Reseau Innovative Clinical Research in Vaccinology (IREIVAC), Paris, France; Centre d'Investigation Clinique Cochin Pasteur, Paris, France; Université de Paris, Paris, France. Electronic address: liem.luong@aphp.fr., Magloire L; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France., François A; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France., Billard D; Oncologie et soins de support, Hôpital Foch, Suresnes, France., Priou F; Service Oncohématologie Médecine Interne, Centre Hospitalier Départemental Vendée, La Roche-Sur-Yon, France., Arrondeau J; Department of Medical Oncology, Cochin University Hospital, Institut du Cancer Paris CARPEM, AP-HP, Paris, France., Linassier C; Department of Medical Oncology, Centre Hospitalier Régional Universitaire, 37000 Tours, France., Ben Ghezala I; INSERM, CIC 1432, Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, University Hospital Dijon-Burgundy, Dijon, France., Gross-Goupil M; Department of Medical Oncology, Saint-André University Hospital, Bordeaux, France; Inserm, F-CRIN, Réseau Innovative Clinical Research in Vaccinology (I-REIVAC), Paris, France., Charles J; Dermatology Department, CHU Grenoble Alpes, University Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institut for Advanced Biosciences, Grenoble, France., Dohollou N; Department of Medical Oncology, Polyclinique Bordeaux Nord Aquitaine, Unicancer Bordeaux, France., Vanhems P; Service Hygiène, Épidémiologie, Infectiovigilance Et Prévention, Hôpital Edouard Herriot, Hospices Civils de Lyon - Equipe Epidémiologie et Santé Publique Université Claude Bernard Lyon 1, Lyon, France., Cracowski C; Inserm Centre d'Investigation Clinique 1406, Centre Hospitalier Grenoble-Alpes, Grenoble, France., Leroi AM; Univ Rouen Normandie, CIC-CRB 1404, CHU Rouen, F-76000 Rouen, France., Lainé F; INSERM CIC 1414, Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Rennes, France., Galtier F; INSERM CIC 1411, Centre Hospitalier Universitaire de Montpellier, Hôpital Saint-Eloi, Montpellier, France., Barthelemy K; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Priet S; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Gharib M; ANRS Maladies infectieuses émergentes (ANRS MIE), Paris, France., Chalouni M; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France., Barquin A; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France., Loubet P; INSERM, F-CRIN, Reseau Innovative Clinical Research in Vaccinology (IREIVAC), Paris, France; Service des Maladies Infectieuses et Tropicales, CHU de Nîmes, Nîmes, France; INSERM U1047 - Université de Montpellier, Nîmes, France., de Lamballerie X; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France., Launay O; INSERM, F-CRIN, Reseau Innovative Clinical Research in Vaccinology (IREIVAC), Paris, France; Centre d'Investigation Clinique Cochin Pasteur, Paris, France; Université de Paris, Paris, France., Wittkop L; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France; CHU de Bordeaux, Service d'information medicale, INSERM, Institut Bergonie, CIC-EC 1401, Bordeaux, France; Inria équipe SISTM, Talence, France., Blay JY; Centre Léon-Bérard, Département de cancérologie médicale, Lyon, France; Université Claude Bernard Lyon, Unicancer, Lyon, France., Spano JP; Sorbonne université, Inserm, institut Pierre-Louis d'épidémiologie et de santé publique (IPLESP), équipe TheraVir, AP-HP, Hôpital universitaire Pitié-Salpêtrière, Oncologie médicale, CLIP(2) Galilée, Paris, France. |
| Corporate Authors: | ANRS0001S COV-POPART cohort study group |
| Source: | Vaccine [Vaccine] 2025 Sep 17; Vol. 63, pp. 127633. Date of Electronic Publication: 2025 Aug 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40848673 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Luong+Nguyen+LB%22">Luong Nguyen LB</searchLink>; INSERM, F-CRIN, Reseau Innovative Clinical Research in Vaccinology (IREIVAC), Paris, France; Centre d'Investigation Clinique Cochin Pasteur, Paris, France; Université de Paris, Paris, France. Electronic address: liem.luong@aphp.fr.<br /><searchLink fieldCode="AU" term="%22Magloire+L%22">Magloire L</searchLink>; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22François+A%22">François A</searchLink>; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Billard+D%22">Billard D</searchLink>; Oncologie et soins de support, Hôpital Foch, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Priou+F%22">Priou F</searchLink>; Service Oncohématologie Médecine Interne, Centre Hospitalier Départemental Vendée, La Roche-Sur-Yon, France.<br /><searchLink fieldCode="AU" term="%22Arrondeau+J%22">Arrondeau J</searchLink>; Department of Medical Oncology, Cochin University Hospital, Institut du Cancer Paris CARPEM, AP-HP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Linassier+C%22">Linassier C</searchLink>; Department of Medical Oncology, Centre Hospitalier Régional Universitaire, 37000 Tours, France.<br /><searchLink fieldCode="AU" term="%22Ben+Ghezala+I%22">Ben Ghezala I</searchLink>; INSERM, CIC 1432, Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, University Hospital Dijon-Burgundy, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Gross-Goupil+M%22">Gross-Goupil M</searchLink>; Department of Medical Oncology, Saint-André University Hospital, Bordeaux, France; Inserm, F-CRIN, Réseau Innovative Clinical Research in Vaccinology (I-REIVAC), Paris, France.<br /><searchLink fieldCode="AU" term="%22Charles+J%22">Charles J</searchLink>; Dermatology Department, CHU Grenoble Alpes, University Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institut for Advanced Biosciences, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Dohollou+N%22">Dohollou N</searchLink>; Department of Medical Oncology, Polyclinique Bordeaux Nord Aquitaine, Unicancer Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Vanhems+P%22">Vanhems P</searchLink>; Service Hygiène, Épidémiologie, Infectiovigilance Et Prévention, Hôpital Edouard Herriot, Hospices Civils de Lyon - Equipe Epidémiologie et Santé Publique Université Claude Bernard Lyon 1, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Cracowski+C%22">Cracowski C</searchLink>; Inserm Centre d'Investigation Clinique 1406, Centre Hospitalier Grenoble-Alpes, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Leroi+AM%22">Leroi AM</searchLink>; Univ Rouen Normandie, CIC-CRB 1404, CHU Rouen, F-76000 Rouen, France.<br /><searchLink fieldCode="AU" term="%22Lainé+F%22">Lainé F</searchLink>; INSERM CIC 1414, Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Galtier+F%22">Galtier F</searchLink>; INSERM CIC 1411, Centre Hospitalier Universitaire de Montpellier, Hôpital Saint-Eloi, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Barthelemy+K%22">Barthelemy K</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Priet+S%22">Priet S</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Gharib+M%22">Gharib M</searchLink>; ANRS Maladies infectieuses émergentes (ANRS MIE), Paris, France.<br /><searchLink fieldCode="AU" term="%22Chalouni+M%22">Chalouni M</searchLink>; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Barquin+A%22">Barquin A</searchLink>; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Loubet+P%22">Loubet P</searchLink>; INSERM, F-CRIN, Reseau Innovative Clinical Research in Vaccinology (IREIVAC), Paris, France; Service des Maladies Infectieuses et Tropicales, CHU de Nîmes, Nîmes, France; INSERM U1047 - Université de Montpellier, Nîmes, France.<br /><searchLink fieldCode="AU" term="%22de+Lamballerie+X%22">de Lamballerie X</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), France.<br /><searchLink fieldCode="AU" term="%22Launay+O%22">Launay O</searchLink>; INSERM, F-CRIN, Reseau Innovative Clinical Research in Vaccinology (IREIVAC), Paris, France; Centre d'Investigation Clinique Cochin Pasteur, Paris, France; Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Wittkop+L%22">Wittkop L</searchLink>; Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France; CHU de Bordeaux, Service d'information medicale, INSERM, Institut Bergonie, CIC-EC 1401, Bordeaux, France; Inria équipe SISTM, Talence, France.<br /><searchLink fieldCode="AU" term="%22Blay+JY%22">Blay JY</searchLink>; Centre Léon-Bérard, Département de cancérologie médicale, Lyon, France; Université Claude Bernard Lyon, Unicancer, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Spano+JP%22">Spano JP</searchLink>; Sorbonne université, Inserm, institut Pierre-Louis d'épidémiologie et de santé publique (IPLESP), équipe TheraVir, AP-HP, Hôpital universitaire Pitié-Salpêtrière, Oncologie médicale, CLIP(2) Galilée, Paris, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ANRS0001S+COV-POPART+cohort+study+group%22">ANRS0001S COV-POPART cohort study group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2025 Sep 17; Vol. 63, pp. 127633. <i>Date of Electronic Publication: </i>2025 Aug 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40848673 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2025.127633 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 127633 Titles: – TitleFull: Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Luong Nguyen LB – PersonEntity: Name: NameFull: Magloire L – PersonEntity: Name: NameFull: François A – PersonEntity: Name: NameFull: Billard D – PersonEntity: Name: NameFull: Priou F – PersonEntity: Name: NameFull: Arrondeau J – PersonEntity: Name: NameFull: Linassier C – PersonEntity: Name: NameFull: Ben Ghezala I – PersonEntity: Name: NameFull: Gross-Goupil M – PersonEntity: Name: NameFull: Charles J – PersonEntity: Name: NameFull: Dohollou N – PersonEntity: Name: NameFull: Vanhems P – PersonEntity: Name: NameFull: Cracowski C – PersonEntity: Name: NameFull: Leroi AM – PersonEntity: Name: NameFull: Lainé F – PersonEntity: Name: NameFull: Galtier F – PersonEntity: Name: NameFull: Barthelemy K – PersonEntity: Name: NameFull: Priet S – PersonEntity: Name: NameFull: Gharib M – PersonEntity: Name: NameFull: Chalouni M – PersonEntity: Name: NameFull: Barquin A – PersonEntity: Name: NameFull: Loubet P – PersonEntity: Name: NameFull: de Lamballerie X – PersonEntity: Name: NameFull: Launay O – PersonEntity: Name: NameFull: Wittkop L – PersonEntity: Name: NameFull: Blay JY – PersonEntity: Name: NameFull: Spano JP IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 09 Text: 2025 Sep 17 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 63 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |